Literature DB >> 24575167

Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhotics.

Bashar M Attar1, Magdalena George1, Nicolae Ion-Nedelcu1, Guilliano Ramadori1, David H Van Thiel1.   

Abstract

AIM: To assess differing patterns and levels of ascitic fluid cyctokine and growth factors exist between those with a high risk and low risk of spontaneous bacterial peritonitis (SBP).
METHODS: A total of 57 consecutive patients with ascites requiring a large volume paracentesis were studied. Their age, gender, specific underlying disease conditions were recorded after a review of their clinical records. Each underwent a routine assessment prior to their paracentesis consisting of a complete blood count, complete metabolic profile and prothrombin time/international normalized ratio (INR) determination. The ascitic fluid was cultured and a complete cell count and albumin determination was obtained on the fluid. In addition, blood and ascitic fluid was assessed for the levels of interleukin interleukin (IL)-1A, IL-1B, IL-2, IL-4, IL-8, IL-10, monocyte chemotactic protein (MCP)-1, tumor necrosis factor (TNF)-α, interferon (IFN)-γ, vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) utilizing the Randox Biochip platforms (Boston, MA). A serum-ascites gradient, for each cytokine and growth factor was calculated. The results are reported as mean ± SEM between disease groups with statistical analysis consisting of the student t-test (two tailed) with a P value of 0.05 defining significance.
RESULTS: No clinically important demographic or biochemical differences between the 4 groups studied were evident. In contrast, marked difference in the cytokine and growth factors levels and pattern were evident between the 4 disease groups. Individuals with alcoholic cirrhosis had the highest levels of IL-1A, IL-1B, IL-4, IFNγ. Those with malignant disease had the highest levels of IL-2. Those with hepatitis C virus (HCV) associated cirrhosis had the highest value for IL-6, IL-8, IL-10, MCP-1 and VEGF. Those with cardiac disease had the highest level of TNF-α and EGF. The calculated serum- ascites gradients for the cardiac and malignant disease groups had a greater frequency of negative values signifying greater levels of IL-8, IL-10 and MCP-1 in ascites than did those with alcohol or HCV disease.
CONCLUSION: These data document important differences in the cytokine and growth factor levels in plasma, ascitic fluid and the calculated plasma - ascites fluid gradients in cirrhotics requiring a large volume paracentesis. These differences may be important in determining the risk for bacterial peritonitis.

Entities:  

Keywords:  Ascites; Cirrhosis; Growth factors; Inflammation; Procalcitonin

Year:  2014        PMID: 24575167      PMCID: PMC3934639          DOI: 10.4254/wjh.v6.i2.85

Source DB:  PubMed          Journal:  World J Hepatol


  14 in total

1.  Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.

Authors:  Maria Papp; Zsuzsanna Vitalis; Istvan Altorjay; Istvan Tornai; Miklos Udvardy; Jolan Harsfalvi; Andras Vida; Janos Kappelmayer; Peter L Lakatos; Peter Antal-Szalmas
Journal:  Liver Int       Date:  2011-12-06       Impact factor: 5.828

2.  Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.

Authors:  Murat Kiyici; Selim Giray Nak; Ferah Budak; Selim Gurel; Barbaros Oral; Enver Dolar; Macit Gulten
Journal:  J Gastroenterol Hepatol       Date:  2006-06       Impact factor: 4.029

3.  Bacterial translocation and immunohistochemical measurement of gut immune function.

Authors:  N P Woodcock; J Robertson; D R Morgan; K L Gregg; C J Mitchell; J MacFie
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

4.  Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

Authors:  D Gendrel; J Raymond; J Coste; F Moulin; M Lorrot; S Guérin; S Ravilly; H Lefèvre; C Royer; C Lacombe; P Palmer; C Bohuon
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

5.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

Authors:  D M Klinman; A K Yi; S L Beaucage; J Conover; A M Krieg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

6.  Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.

Authors:  Rubén Francés; José M González-Navajas; Pedro Zapater; Carlos Muñoz; Rocío Caño; Sonia Pascual; Dorkas Márquez; Francia Santana; Miguel Pérez-Mateo; José Such
Journal:  J Clin Immunol       Date:  2007-04-03       Impact factor: 8.317

7.  Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines.

Authors:  A Viallon; F Zeni; V Pouzet; C Lambert; S Quenet; G Aubert; S Guyomarch; B Tardy; J C Bertrand
Journal:  Intensive Care Med       Date:  2000-08       Impact factor: 17.440

Review 8.  Fibrosis and cirrhosis reversibility: clinical features and implications.

Authors:  Massimo Pinzani; Francesco Vizzutti
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

9.  Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.

Authors:  Takanori Mukozu; Hidenari Nagai; Daigo Matsui; Takenori Kanekawa; Yasukiyo Sumino
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

10.  Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites.

Authors:  R Francés; C Muñoz; P Zapater; F Uceda; I Gascón; S Pascual; M Pérez-Mateo; J Such
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

View more
  3 in total

Review 1.  Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?

Authors:  Hiroshi Fukui
Journal:  Inflamm Intest Dis       Date:  2016-07-20

Review 2.  Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.

Authors:  Hiroshi Fukui
Journal:  J Clin Transl Hepatol       Date:  2017-06-29

3.  Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis.

Authors:  Yongtao Yang; Lianyong Li; Changmin Qu; Bolun Zeng; Shuwen Liang; Zhiwen Luo; Xiaoying Wang; Changqing Zhong
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.